Studies according to Group Health and the University of Washington suggest the popular osteoporosis drug, Fosamax, is linked to a heart problem known as atrial fibrillation.
700 women with atrial
fibrillation were compared against 900 women without heart rhythm disturbances, and the results showed women who had used Fosamax had nearly doubled their chances to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) compared to those women who had never used the drug.
More intensive research and study is needed to confirm the results. Even if it is proven true, authors of this research claim the benfits of Fosamax outweigh the negative side effects. However, women with extremely high risks for heart problems should consult with their physician for an alternative treatment.